Clinical and Translational Radiation Oncology

Article	Citations
Spatially fractionated radiotherapy (Lattice SFRT) in the palliative treatment of locally advanced bulky unresectable head and neck cancer	42
In response to Chuong et al.	26
Local relapse patterns after preoperative radiotherapy of limb and trunk wall soft tissue sarcomas: Prognostic role of imaging and pathologic response factors	23
HDR brachytherapy versus robotic-based and linac-based stereotactic ablative body radiotherapy in the treatment of liver metastases – A dosimetric comparison study of three radioablative techniques	22
Exploring long-term outcomes following CyberKnife robotic radiosurgery for trigeminal neuralgia	20
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center	19
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey	16
Postoperative brachytherapy alone for 217 patients with early-stage oral cavity squamous cell carcinoma	13
Fully automatic reconstruction of prostate high-dose-rate brachytherapy interstitial needles using two-phase deep learning-based segmentation and object tracking algorithms	13
Uterus motion analysis for radiotherapy planning optimization. The innovative contribution of on-board hybrid MR imaging	12
Real-world outcomes of prophylactic cranial irradiation utilization and efficacy for patients with extensive-stage small cell lung cancer treated with consolidative thoracic radiotherapy	12
Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged ≥ 60 years with Early-stage breast cancer (EPOPE): The rationale	11
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)	11
Adjuvant locoregional radiation therapy in breast cancer patients with pathologic complete response after neoadjuvant chemotherapy: A systematic review and meta-analysis	11
In response to Korreman s. et al. Radiation oncologists are, above all, medical doctors	10
Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma	10
Time management: Improving the timing of post-prostatectomy radiotherapy, clinical trials, and knowledge translation	9
Improved Pathologic response to chemoradiation in MGMT methylated locally advanced rectal cancer	9
Postoperative radiotherapy alone is as effective as postoperative chemoradiotherapy in patients with pT4aN0 gingival cancer with negative surgical margins	9
Local control and radionecrosis of brain metastases from non-small-cell lung cancer treated by hypofractionated stereotactic radiotherapy: Evaluation of predictive factors	8
Hypofractionation of radiation dose to the prostate does not necessarily imply a greater risk of acute radiation proctitis	8
Identifying predictors of on-table adaptation for pancreas stereotactic body radiotherapy (SBRT)	8
A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity	8
The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis	8
Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience	8

Radiomics biopsy signature for predicting survival in patients with spinal bone metastases (SBMs)	7
Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer	7
Incorporating axillary-lateral thoracic vessel juncture dosimetric variables improves model for predicting lymphedema in patients with breast cancer: A validation analysis	7
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States – Understanding the transition to adaptive, ultra-hypofractionated treatments	7
Cervical body composition on radiotherapy planning computed tomography scans predicts overall survival in glioblastoma patients	7
The efficacy profiles of concurrent chemoradiotherapy with intensity-modulated radiotherapy followed by durvalumab in patients with unresectable stage III non–small cell lung cancer: A multicenter ret	7
Prospective Pilot study of Quality of Life in patients with severe late-radiation-toxicity treated by Low hyperbaric-oxigen-therapy	7
Reduced-dose WBRT combined with SRS for 1–4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control	7
Treatment of an unresectable cardiac angiosarcoma using paclitaxel and image guided radiotherapy: Case report and literature review	7
A simple solution to create a custom scalp-sparing helmet to prevent alopecia in patients undergoing total skin electron beam therapy for cutaneous T cell lymphoma	7
GI factors, potential to predict prostate motion during radiotherapy; a scoping review	6
Dose constraints for whole breast radiation therapy based on the quality assessment of treatment plans in the randomised Danish breast cancer group (DBCG) HYPO trial	6
18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer	6
Imaging response assessment for predicting outcomes after bioselection chemotherapy in larynx cancer: A secondary analysis of two prospective trials	6
Measuring patient reported outcomes in brachytherapy: Why we should do it and more importantly how	6
The association between diarrhea and serum cytokines in patients with gynecologic cancer treated with surgery and pelvic chemoradiotherapy	6
Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan	6
Clinical relevance of the radiation dose bath in lower grade glioma, a cross-sectional pilot study on neurocognitive and radiological outcome	6
Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy	6
Analysis of data to Advance Personalised Therapy with MR-Linac (ADAPT-MRL)	6
Machine learning for dose-volume histogram based clinical decision-making support system in radiation therapy plans for brain tumors	6
Dosimetric analysis of 17 cardiac Sub-structures, Toxicity, and survival in ultra central lung tumor patients treated with SBRT	5
Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study	5
Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience	5
Determining risk and predictors of head and neck cancer treatment-related lymphedema: A clinicopathologic and dosimetric data mining approach using interpretable machine learning and ensemble feature	5
Evaluation of 68Ga-FAPI PET/CT and 18F-FDG PET/CT for the diagnosis of recurrent colorectal cancers	5
Comparison of intratumor and local immune response between MV X-ray FLASH and conventional radiotherapies	5
Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease	5
Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy	5
Individual benefit in heart sparing during DIBH-supported left breast radiotherapy	5
Moderately hypofractionated prostate-only versus whole-pelvis radiotherapy for high-risk prostate cancer: A retrospective real-world single-center cohort study	5
Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial	5
Symptomatic radiation-induced rib fractures after stereotactic body radiotherapy for early-stage non-small cell lung cancer	5
Influence of intestinal microbial metabolites on the abscopal effect after radiation therapy combined with immune checkpoint inhibitors	5
Application and progress of artificial intelligence in radiation therapy dose prediction	5
ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer	5
All for one: Collaboration between dermatologist, radiation oncologist and radiologist in the clinical management of “difficult to treat” non melanoma skin cancer	4
Inhibition of OXPHOS induces metabolic rewiring and reduces hypoxia in murine tumor models	4
PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer	4
Radiotherapy induces an increase in serum antioxidant capacity reflecting tumor response	4
Ex vivo radiation sensitivity assessment for individual head and neck cancer patients using deep learning-based automated nuclei and DNA damage foci detection	4
A time-resolved clonogenic assay for improved cell survival and RBE measurements	4
ESTRO guidelines for developing questionnaires in survey-based radiation oncology research	4
Bridging the care gap: patients’ needs and experiences regarding shared decision-making in radiotherapy	4
Validity test of small cell lung cancer (SCLC) graded prognostic assessment and proposal of a new index for patients with brain metastases from SCLC	4
Radiation response assessment of organoids derived from patients with pancreatic cancer	4
Stereotactic body radiation therapy for adrenal gland metastases: A multi-institutional outcome analysis	4
Early radiologic and metabolic tumour response assessment during combined chemo-radiotherapy for locally advanced NSCLC	4
Postmastectomy radiation therapy in breast cancer patients with micrometastatic disease in sentinel node dissection: A cohort study and meta-analysis	4
Maximum disease diameter is associated with outcomes in stage II follicular lymphoma treated with radiation therapy alone	4

Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer – A scoping review	4
Multi-institutional experience of MR-guided stereotactic body radiation therapy for adrenal gland metastases	4
Comparison of lifetime attributable risk of post-irradiation secondary cancer of boron neutron capture therapy, proton beam therapy, and X-ray therapy for pediatric and adolescent and young adult pati	4
The current status of brachytherapy in Europe − A GEC-ESTRO Brachy-HERO survey	4
Extramedullary hematopoiesis causing spinal cord compression in polycythemia vera: A case report and literature review	4
A first evaluation of the efficacy of minibeam radiation therapy combined with an immune check point inhibitor in a model of glioma-bearing rats	4
Determining the gross tumor volume for hepatocellular carcinoma radiotherapy based on multi-phase contrast-enhanced magnetic resonance imaging	4
Letter to the Editor	4
Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives	4
Stereotactic body radiation therapy to postpone systemic therapy escalation for castration-resistant prostate cancer: A multicenter retrospective analysis	4
Impact of reduced margin pelvic radiotherapy on gastrointestinal toxicity and outcome in gynecological cancer	4
Is single fraction the future of stereotactic body radiation therapy (SBRT)? A critical appraisal of the current literature	4
Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy	4
C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect	4
Patterns of failure for recurrent head and neck squamous cell carcinoma treated with salvage surgery and postoperative IMRT reirradiation	4
Radiomics of skeletal muscle helps to predict gastrointestinal toxicity in locally advanced rectal cancer patients receiving neoadjuvant chemoradiotherapy	4
Clinical implementation of RTT-only CBCT-guided online adaptive focal radiotherapy for bladder cancer	4
Effectiveness, toxicity and impact on quality of life of high-dose-rate brachytherapy delivered in two fractions as monotherapy in patients with prostate cancer	4
Value of 18F-fluorocholine PET/CT in predicting response to radical radiotherapy in patients with localized prostate cancer	4
Stabilised Hyaluronic Acid (sHA) gel as a novel marker for breast cancer tumour bed cavity: Surgical feasibility	4
A knowledge graph representation of baseline characteristics for the Dutch proton therapy research registry	4
Dynamic changes in cardiac biomarkers in radiotherapy for oesophageal cancer and their correlations with cardiac radiation dosimetry	4
Enhancing radiotherapy outcomes in rectal cancer: A systematic review of targeting hypoxia-induced radioresistance	4
An impact model to understand and improve work-life balance in early-career researchers in radiation oncology	3
PTCOG international survey of practice patterns and trends in utilization of proton therapy for breast cancer	3
Stereotactic body radiation therapy in patients with centrally located hepatocellular carcinoma: A retrospective, single-arm, multi-center study	3
First treatments for Lattice stereotactic body radiation therapy using magnetic resonance image guided radiation therapy	3
A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer	3
Stable use of radiotherapy in lymphoma patients over time – A comprehensive national overview of radiotherapy use in Sweden with focus on older patients	3
Lung SBRT credentialing in the Canadian OCOG-LUSTRE randomized trial	3
Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients	3
Re-irradiation with concurrent and maintenance nivolumab in locally recurrent and inoperable squamous cell carcinoma of the head and neck: A single-center cohort study	3
Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma	3
4D-MRI assisted stereotactic body radiation therapy for unresectable colorectal cancer liver metastases	3
MR-guided stereotactic radiation therapy for head and neck cancers	3
External validation of Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose (CHyLL) for predicting major adverse cardiac events after lung cancer radi	3
Contact X-ray Brachytherapy as a sole treatment in selected patients with early rectal cancer – Multi-centre study	3
Utility of interim apparent diffusion coefficient value in predicting treatment response among patients with locally advanced cervical cancer treated with radiotherapy	3
ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy	3
Blood-brain barrier permeability following conventional photon radiotherapy – A systematic review and meta-analysis of clinical and preclinical studies	3
Single-institution analysis of the prevalence, indications and outcomes of end-of-life radiotherapy	3
Hypofractionated radiotherapy combined with targeted therapy or immunotherapy: Dutch survey on current practice, knowledge and challenges	3
Metformin with neoadjuvant chemoradiation to improve pathologic response in rectal cancer: A pilot phase I/II trial	3
Rate of pachymeningeal failure following adjuvant WBRT vs SRS in patients with brain metastases	3
Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience	3
Redefining postmastectomy radiation contouring in the era of immediate breast reconstruction: An accurate assessment of local recurrence risk	3
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial	3
Neoadjuvant chemoradiotherapy up-regulates PD-L1 in radioresistant colorectal cancer	3
Anatomical and dosimetric variations during volumetric modulated arc therapy in patients with locally advanced nasopharyngeal carcinoma after induction therapy: Implications for adaptive radiation the	3
Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer	3
Clinical implementation of standardized neurocognitive assessment before and after radiation to the brain	3
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence	3
Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system: A prospective R-IDEAL stage 2a imaging biomarker characterizat	3
Phase I/II trial of concurrent extracranial palliative radiation therapy with Dabrafenib and Trametinib in metastatic BRAF V600E/K mutation-positive cutaneous Melanoma	3
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)	3
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study	3
Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma	3
Do We Have a Winner? Advocating for SBRT in HCC Management	3
Brachytherapy boost in anal canal cancer – A GEC ESTRO PDR task force meta-analysis	3
Prostate cancer radiotherapy and incidental testicular irradiation: Impact on gonadal function	3
Re-irradiation to the prostate using stereotactic body radiotherapy (SBRT) after initial definitive radiotherapy – A systematic review and meta-analysis of recent trials	2
Cleaning radiotherapy contours for radiomics studies, is it worth it? A head and neck cancer study	2
Empirical planning target volume modeling for high precision MRI guided intracranial radiotherapy	2
Association between radiotherapy protocol variations and outcome in the CONVERT trial	2
Systemic therapy escalation after stereotactic body radiation therapy for oligometastatic hormone-sensitive prostate cancer	2
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation	2
Considerations regarding carotid artery dose in radiotherapy of the cervical spine	2
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group	2
MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study	2
Bladder-preserving radiation therapy for patients with locally advanced and node-positive bladder cancer	2
Feasibility of breast radiation therapy in a Fanconi Anemia patient diagnosed with breast cancer: A case report and review of literature	2
The ROCOCO performance scoring system translates dosimetric differences into clinically relevant endpoints: Comparing IMPT to VMAT in an example pilocytic astrocytoma dataset	2
Exclusion of non-Involved uterus from the target volume (EXIT-trial): An individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques followed by comp	2
Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk	2
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study	2
Effects of proton therapy on regional [18F]FDG uptake in non-tumor brain regions of patients treated for head and neck cancer	2
Artificial intelligence to predict outcomes of head and neck radiotherapy	2
A pilot study of same-day MRI-only simulation and treatment with MR-guided adaptive palliative radiotherapy (MAP-RT)	2
Avoiding prostate bed radiation for the PSMA-PET detected nodal recurrence patient post prostatectomy	2
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study	2

Clinical evaluation of a deep learning CBCT auto-segmentation software for prostate adaptive radiation therapy	2
Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma	2
New curative approach using embolization followed by moderate-dose radiotherapy after surgical failure for large right heart metastasis	2
A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic	2
Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma	2
Regional nodal irradiation (RNI) in breast cancer patients with residual isolated tumor cells or micrometastatic nodal disease after neoadjuvant chemotherapy	2
Limited-stage small cell lung cancer: Outcomes associated with prophylactic cranial irradiation over a 20-year period at the Princess Margaret Cancer Centre	2
An exploratory analysis of MR-guided fractionated stereotactic radiotherapy in patients with brain metastases	2
Long-term outcomes of more than a decade treating patients with stereotactic body radiation therapy for hepatocellular carcinoma	2
Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study	2
Feasibility of biology-guided radiotherapy for metastatic renal cell carcinoma driven by PSMA PET imaging	2
Comment on Hunt et al, “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”	2
The impact of rectal spacers in MR-guided adaptive radiotherapy	2
Nomogram for radiation-induced lymphopenia in patients receiving intensity-modulated radiotherapy based-chemoradiation therapy for newly diagnosed glioblastoma: A multi-institutional study	2
Total dose, fraction dose and respiratory motion management impact adrenal SBRT outcome	2
Pelvic insufficiency fractures after intensity modulated radiation therapy combined with chemotherapy for cervix carcinoma: Incidence and impact of bone mineral density	2
Metastases-directed radiotherapy in castration resistant oligo metastatic prostate cancer: A multicentric retrospective study from the French group COLib	2
Lung cancer epidermal growth factor receptor mutations and radiotherapy response: A multicentre clinical study	2
Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)	2
Prospective evaluation of intensity-modulated radiotherapy toxicity in extremity soft tissue sarcomas patients: A role for irradiated healthy soft tissue volume?	2
Elective pelvic nodal irradiation in elderly men treated with hypofractionated radiotherapy	2
Organ-sparing techniques and dose-volume constrains used in breast cancer radiation therapy – Results from European and Latin American surveys	2
Second malignancies in patients with Hodgkin’s Lymphoma: Half a century of experience	2
Comment on Hunt et al., “Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer”	2
10-Year oncological outcome report after second conservative treatment for ipsilateral breast tumor event	2
#radonc: Growth of the global radiation oncology Twitter network	2
Evaluating the radiosensitivity of the oral microbiome to predict radiation-induced mucositis in head and neck cancer patients: A prospective trial	2
Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review	2
Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases	2
Feasibility of tumour-focused adaptive radiotherapy for bladder cancer on the MR-linac	2
A retrospective review of the long-term outcomes of online adaptive radiation therapy and conventional radiation therapy for muscle invasive bladder cancer	2
Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal	2
A single-institution phase I feasibility study of dose-escalated IMRT for non-operative locally advanced esophageal carcinoma	2
Overall survival nomogram for patients with spinal bone metastases (SBM)	2
Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials	2
A total inverse planning paradigm: Prospective clinical trial evaluating the performance of a novel MR-based 3D-printed head immobilization device	2
Weekly ultra-hypofractionated radiotherapy in localised prostate cancer	2
Construction and validation of a prognostic nine-gene signature associated with radiosensitivity in head and neck squamous cell carcinoma	2
Stereotactic ablative radiotherapy for treating primary head and neck cancer and locoregional recurrence: A comprehensive review of the literature	2
Developing and validating a simple urethra surrogate model to facilitate dosimetric analysis to predict genitourinary toxicity	2
Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer	2
Personalizing dental screening and prevention protocols in dentulous patients with oropharyngeal cancer undergoing radiotherapy: A retrospective cohort study	2
Total skin electron beam therapy for cutaneous T-cell lymphomas in the Netherlands: A retrospective analysis of treatment outcomes and selection for high or low dose schedule	2
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol	2